Search results
- shrinking of the varicose blood vessels by the injection of medicine2 statements, 0 sitelinks - 20:30, 8 February 2024
- | routes_of_administration = [[Subcutaneous injection/ja|皮下]] ...あり、[[1型糖尿病|Ⅰ型糖尿病]]および[[type II diabetes/ja|2型糖尿病]]の管理に用いられる。[[subcutaneous injection/ja|皮膚のすぐ下に注射する]]。効果は一般に使用後1時間で始まる。 ...11 KB (501 words) - 08:49, 21 March 2024
- | routes_of_administration = [[Subcutaneous injection|Subcutaneous]] ...ent of [[type 1 DM|type I]] and [[type II diabetes]]. It is [[subcutaneous injection|injected just under the skin]]. Effects generally begin an hour after use. ...9 KB (1,241 words) - 11:01, 20 March 2024
- | routes_of_administration = [[Subcutaneous injection|Subcutaneous]] ...ent of [[type 1 DM|type I]] and [[type II diabetes]]. It is [[subcutaneous injection|injected just under the skin]]. Effects generally begin an hour after use. ...9 KB (1,299 words) - 11:00, 20 March 2024
- ...se, and certain types of [[mushroom poisoning]]. It is used by mouth or by injection. As a treatment (oral or injection), it is used to treat or prevent [[pyridoxine deficiency]], [[sideroblastic ...7 KB (835 words) - 20:46, 3 April 2024
- [[File:Inyección subcutánea.ogg|thumb|3D animation of a subcutaneous injection]] ...ministration''' is the insertion of medications beneath the skin either by injection or infusion. ...22 KB (2,885 words) - 17:22, 3 January 2023
- ...se, and certain types of [[mushroom poisoning]]. It is used by mouth or by injection. As a treatment (oral or injection), it is used to treat or prevent [[pyridoxine deficiency]], [[sideroblastic ...7 KB (869 words) - 20:46, 3 April 2024
- {{Short description|Medical injection into a muscle}} | Name = Intramuscular injection ...29 KB (4,153 words) - 17:21, 3 January 2023
- ...an be easier and less painful than other routes of administration, such as injection. However, the onset of action is relatively low, and the effectiveness is r ...medicine to describe a treatment that is taken orally (but not used [[Oral medicine|''in'' the mouth]] such as, for example, [[caries]] prophylaxis).<ref>{{cit ...5 KB (672 words) - 21:02, 15 November 2023
- | routes_of_administration = [[By mouth]], [[intramuscular injection|intramuscular]] 2010年の[[:en:Institute of Medicine|Institute of Medicine]]では、ビタミンDの最大摂取量は4,000 IU/日を推奨し、最も副作用が少ない用量は1日40,000 IUを12週間以上摂取することであり、1日10 ...21 KB (1,011 words) - 10:09, 12 April 2024
- ...s optic atrophy]], and [[toxic amblyopia]]. It is given by [[intramuscular|injection into a muscle]] or [[intravenous|vein]]. ...clear red liquid solution. Shown is 500 μg B-12 prepared for subcutaneous injection.]] ...12 KB (1,664 words) - 10:35, 7 April 2024
- ...s optic atrophy]], and [[toxic amblyopia]]. It is given by [[intramuscular|injection into a muscle]] or [[intravenous|vein]]. ...clear red liquid solution. Shown is 500 μg B-12 prepared for subcutaneous injection.]] ...12 KB (1,708 words) - 10:35, 7 April 2024
- ...utaneous injection/ja|皮下]], [[Intravenous therapy/ja|静脈]], [[Intramuscular injection/ja|筋肉]], [[Inhalation administration/ja|吸入]] ...ction under the skin/ja|皮下注射]]で投与されるが、[[injection into a vei/ja|静脈への注射]]や[[injection into a muscle/ja|筋注]]で使用される場合もある。インスリンには様々な種類があり、様々な時間スパンに適している。しかし、より正確な意味 ...69 KB (1,887 words) - 11:33, 22 March 2024
- ...[[low blood calcium]], [[osteoporosis]], and [[rickets]]. By [[intravenous|injection into a vein]] they are used for low blood calcium that is resulting in [[mu ...preventative effect against developing [[colorectal]] adenomatous [[polyp (medicine)|polyp]]s, but the evidence is not sufficient to recommend such supplementa ...10 KB (1,402 words) - 20:16, 4 February 2024
- ...[[low blood calcium]], [[osteoporosis]], and [[rickets]]. By [[intravenous|injection into a vein]] they are used for low blood calcium that is resulting in [[mu ...preventative effect against developing [[colorectal]] adenomatous [[polyp (medicine)|polyp]]s, but the evidence is not sufficient to recommend such supplementa ...10 KB (1,448 words) - 20:15, 4 February 2024
- ...aken by mouth, [[intramuscular|injection into a muscle]], or [[intravenous|injection into a vein]]. {{Portal bar|Medicine}} ...10 KB (1,413 words) - 17:58, 5 April 2024
- ...aken by mouth, [[intramuscular|injection into a muscle]], or [[intravenous|injection into a vein]]. {{Portal bar|Medicine}} ...10 KB (1,475 words) - 17:57, 5 April 2024
- | routes_of_administration = [[Subcutaneous injection|Subcutaneous]] ...lar disease]] or multiple cardiovascular risk factors. It is a once-weekly injection. ...9 KB (1,155 words) - 10:30, 12 February 2024
- | routes_of_administration = [[Subcutaneous injection/ja|Subcutaneous]] {{Portal bar | Medicine}} ...10 KB (611 words) - 16:42, 12 February 2024
- | routes_of_administration = [[Subcutaneous injection|Subcutaneous]] ...lar disease]] or multiple cardiovascular risk factors. It is a once-weekly injection. ...9 KB (1,201 words) - 10:29, 12 February 2024